Correlation Between Accolade and 10X Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Accolade and 10X Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Accolade and 10X Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Accolade and 10X Genomics, you can compare the effects of market volatilities on Accolade and 10X Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Accolade with a short position of 10X Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Accolade and 10X Genomics.

Diversification Opportunities for Accolade and 10X Genomics

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Accolade and 10X is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Accolade and 10X Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 10X Genomics and Accolade is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Accolade are associated (or correlated) with 10X Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 10X Genomics has no effect on the direction of Accolade i.e., Accolade and 10X Genomics go up and down completely randomly.

Pair Corralation between Accolade and 10X Genomics

Given the investment horizon of 90 days Accolade is expected to generate 0.06 times more return on investment than 10X Genomics. However, Accolade is 16.5 times less risky than 10X Genomics. It trades about 0.06 of its potential returns per unit of risk. 10X Genomics is currently generating about -0.3 per unit of risk. If you would invest  688.00  in Accolade on November 19, 2024 and sell it today you would earn a total of  2.00  from holding Accolade or generate 0.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Accolade  vs.  10X Genomics

 Performance 
       Timeline  
Accolade 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Accolade are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, Accolade exhibited solid returns over the last few months and may actually be approaching a breakup point.
10X Genomics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days 10X Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, 10X Genomics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Accolade and 10X Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Accolade and 10X Genomics

The main advantage of trading using opposite Accolade and 10X Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Accolade position performs unexpectedly, 10X Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 10X Genomics will offset losses from the drop in 10X Genomics' long position.
The idea behind Accolade and 10X Genomics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges